Sumitomo Mitsui Trust Group
EW icon

Sumitomo Mitsui Trust Group’s Edwards Lifesciences EW Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$114M Sell
1,258,958
-8,425
-0.7% -$706K 0.07% 269
2026
Q1 		$101M Sell
1,267,383
-74,542
-6% -$6.15M 0.07% 275
2025
Q4 		$114M Sell
1,341,925
-39,987
-3% -$3.28M 0.07% 265
2025
Q3 		$107M Buy
1,381,912
+6,576
+0.5% +$514K 0.06% 284
2025
Q2 		$108M Buy
1,375,336
+17,937
+1% +$1.34M 0.07% 271
2025
Q1 		$98.4M Sell
1,357,399
-12,476
-0.9% -$893K 0.07% 276
2024
Q4 		$101M Buy
1,369,875
+4,603
+0.3% +$322K 0.07% 278
2024
Q3 		$90.1M Buy
1,365,272
+1,070
+0.1% +$77.7K 0.06% 307
2024
Q2 		$126M Sell
1,364,202
-245,664
-15% -$21.8M 0.09% 205
2024
Q1 		$154M Buy
1,609,866
+6,563
+0.4% +$551K 0.11% 204
2023
Q4 		$122M Sell
1,603,303
-32,609
-2% -$2.27M 0.09% 233
2023
Q3 		$113M Buy
1,635,912
+37,250
+2% +$2.99M 0.09% 223
2023
Q2 		$151M Sell
1,598,662
-254,997
-14% -$22.2M 0.12% 180
2023
Q1 		$153M Sell
1,853,659
-408,169
-18% -$32.1M 0.11% 193
2022
Q4 		$169M Sell
2,261,828
-216,272
-9% -$16.7M 0.13% 174
2022
Q3 		$205M Sell
2,478,100
-210,359
-8% -$20.2M 0.17% 130
2022
Q2 		$256M Buy
2,688,459
+200,725
+8% +$20.8M 0.2% 110
2022
Q1 		$293M Sell
2,487,734
-503,756
-17% -$56.5M 0.2% 110
2021
Q4 		$388M Sell
2,991,490
-528,474
-15% -$61.6M 0.24% 89
2021
Q3 		$398M Sell
3,519,964
-211,707
-6% -$24.2M 0.25% 91
2021
Q2 		$386M Sell
3,731,671
-194,951
-5% -$18.4M 0.23% 103
2021
Q1 		$328M Buy
3,926,622
+185,231
+5% +$15.7M 0.21% 106
2020
Q4 		$341M Buy
3,741,391
+93,691
+3% +$7.77M 0.22% 99
2020
Q3 		$291M Buy
3,647,700
+141,641
+4% +$11.1M 0.2% 116
2020
Q2 		$242M Buy
3,506,059
+166,084
+5% +$11.8M 0.17% 130
2020
Q1 		$210M Buy
3,339,975
+677,046
+25% +$48.8M 0.18% 131
2019
Q4 		$207M Buy
2,662,929
+9,060
+0.3% +$707K 0.16% 137
2019
Q3 		$195M Buy
2,653,869
+217,635
+9% +$15.3M 0.17% 134
2019
Q2 		$150M Sell
2,436,234
-56,151
-2% -$3.4M 0.13% 178
2019
Q1 		$159M Buy
2,492,385
+36,969
+2% +$2.11M 0.15% 154
2018
Q4 		$123M Buy
2,455,416
+415,863
+20% +$21M 0.13% 175
2018
Q3 		$118M Buy
2,039,553
+56,481
+3% +$2.76M 0.13% 181
2018
Q2 		$96.2M Buy
1,983,072
+114,771
+6% +$5.36M 0.11% 203
2018
Q1 		$86.9M Buy
1,868,301
+61,296
+3% +$2.66M 0.11% 202
2017
Q4 		$67.9M Buy
1,807,005
+33,462
+2% +$1.23M 0.09% 251
2017
Q3 		$64.6M Sell
1,773,543
-27,852
-2% -$1.06M 0.09% 244
2017
Q2 		$71M Buy
1,801,395
+3,729
+0.2% +$136K 0.1% 223
2017
Q1 		$56.4M Sell
1,797,666
-92,211
-5% -$2.89M 0.09% 261
2016
Q4 		$59M Sell
1,889,877
-13,179
-0.7% -$427K 0.1% 246
2016
Q3 		$76.5M Sell
1,903,056
-13,437
-0.7% -$506K 0.13% 195
2016
Q2 		$63.7M Buy
1,916,493
+48,900
+3% +$1.67M 0.11% 223
2016
Q1 		$54.9M Buy
1,867,593
+49,680
+3% +$1.37M 0.1% 246
2015
Q4 		$48M Sell
1,817,913
-28,161
-2% -$731K 0.09% 265
2015
Q3 		$43.7M Buy
1,846,074
+57,048
+3% +$1.38M 0.08% 277
2015
Q2 		$42.5M Sell
1,789,026
-21,666
-1% -$489K 0.08% 300
2015
Q1 		$43M Buy
1,810,692
+226,740
+14% +$5.09M 0.08% 296
2014
Q4 		$34.1M Buy
1,583,952
+21,192
+1% +$426K 0.07% 341
2014
Q3 		$26.6M Sell
1,562,760
-36,072
-2% -$569K 0.05% 405
2014
Q2 		$22.9M Sell
1,598,832
-79,446
-5% -$1.08M 0.05% 438
2014
Q1 		$20.7M Sell
1,678,278
-76,494
-4% -$883K 0.04% 471
2013
Q4 		$19.2M Sell
1,754,772
-76,272
-4% -$860K 0.04% 492
2013
Q3 		$21.2M Buy
1,831,044
+2,376
+0.1% +$27.8K 0.05% 462
2013
Q2 		$20.5M Buy
+1,828,668
New +$21.6M 0.05% 449

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Sumitomo Mitsui Trust Group's EW Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group reduced its Edwards Lifesciences (EW) stake by 0.66% in Q2 2026, selling an estimated $706K and leaving 1,258,958 shares worth $114M. The position accounts for 0.07% of the portfolio, ranked #269.

Sumitomo Mitsui Trust Group first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $398M in Q3 2021. 563 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Sumitomo Mitsui Trust Group held 1,258,958 shares of Edwards Lifesciences worth $114M as of Q2 2026.
  • Sumitomo Mitsui Trust Group sold 8,425 Edwards Lifesciences shares in Q2 2026, an estimated $706K.
  • Edwards Lifesciences made up 0.07% of Sumitomo Mitsui Trust Group's portfolio in Q2 2026, its #269 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
  • Sumitomo Mitsui Trust Group's Edwards Lifesciences position peaked at $398M in Q3 2021.
  • 563 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.